Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and oxytocin versus pethidine for postoperative symptom control after laparoscopic cholecystectomy
IRCT20210108049969N1Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, single-blind trial of ketamine, oxytocin and pethidine in postoperative pain and postoperative nausea and vomiting (PONV) (3 arms), sponsored by Lorestan University of Medical Sciences. Primary endpoints: Postoperative pain, Postoperative nausea and 4 more. Started Dec 2019; status: completed.
02
Drugs
ketamineoxytocinpethidine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20210108049969N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210108049969N1.